Results 181 to 190 of about 368,892 (358)
RADIOACTIVE PHOSPHORUS AS AN INDICATOR OF PHOSPHOLIPID METABOLISM
I. Perlman, I.L. Chaikoff
openalex +1 more source
Phospholipid precursors of prostaglandins [PDF]
William E.M. Lands, Bengt Samuelsson
openalex +1 more source
The DNA demethylase TET3 drives lipid metabolic reprogramming in pancreatic ductal adenocarcinoma via a non‐catalytic mechanism. TET3 recruits histone deacetylases to repress GATA6, sustaining lipogenic enzyme expression and ferroptosis resistance.
Shuai Liu+8 more
wiley +1 more source
Isolation and characterization of proteolipids from rat liver (LSP) and kidney (KSP) [PDF]
Blumenstingl, J.+2 more
core +1 more source
Hydrolysis of phospholipids and glycerides by rat-liver preparations [PDF]
Moseley Waite, L.L.M. Van Deenen
openalex +1 more source
Emerging Nanotechnology Strategies for Obesity Therapy
Three types of nanomaterials used for obesity treatment are highlighted, including inorganic nanomaterials, organic nanomaterials and biomimetic nanomaterials. A detailed and comprehensive introduction to the recent nanotechnology strategies for obesity management is also provided, including drug delivery, photodynamic therapy, hyperthermia, gas ...
Weili Chang+5 more
wiley +1 more source
SeNSs provide a biocompatible, anti‐inflammatory UC therapy. SeNSs form protein coronas enriched with AKT/PI3K/NF‐κB pathway proteins, suppress GP130 via hydrophobic interactions, and inhibit pro‐inflammatory cytokines. In DSS‐induced UC mice, SeNSs reduce inflammation, tissue damage, and disease activity by modulating cytokine, chemokine, and ...
Dingyi Shen+5 more
wiley +1 more source
Lipid metabolism in the adrenal gland. [PDF]
Aderhold A, Alexaki VI.
europepmc +1 more source
THE NATURE OF THE DIFFERENCE IN PHOSPHOLIPID CONTENT OF OXALATED AND HEPARINIZED PLASMA
L. H. Schmidt
openalex +1 more source